NCT03576131 · OUTCOME
Area Under Plasma Concentration-time Curve From Time Zero to Infinity (AUC[0-inf]) of Hx-DR5-01 and Hx-DR5-05
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors · Source last updated 2023-08-01
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- GEOMETRIC_MEAN
- Unit
- µg*h/mL
- Interval / dispersion
- Geometric Coefficient of Variation
- Time frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
What was measured
The AUC(0-inf) of Hx-DR5-01 and Hx-DR5-05 are reported.
Analysis population: PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
Groups in this outcome
Biweekly Regimen (GEN1029 0.1 mg/kg)
Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
Biweekly Regimen (GEN1029 0.2 mg/kg)
Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 0.3 mg/kg)
Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 1.0 mg/kg)
Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 2.0 mg/kg)
Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 3.0 mg/kg)
Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Reported measurements
AUC(0-inf) Hx-DR5-01 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 39.44 | 50.2 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 91.20 | 66.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 85.80 | 56.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 523.66 | 47.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 1298.0 | 22.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1497.7 | 58.7 | Not reported | Not reported | Not reported |
|---|
AUC(0-inf) Hx-DR5-01 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 46.37 | 61.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 105.32 | 55.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 35.24 | 30.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 530.48 | 24.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 1071.5 | 30.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2488.5 | 10.7 | Not reported | Not reported | Not reported |
|---|
AUC(0-inf) Hx-DR5-01 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 37.43 | 74.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 53.24 | 133.3 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 41.41 | 84.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 422.32 | 26.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 1097.8 | 36.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2653.5 | NA | Not reported | Not reported | Geometric coefficient of variation was not derived as only one participant was evaluated for this arm. |
|---|
AUC(0-inf) Hx-DR5-05 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 32.97 | 55.4 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 71.21 | 66.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 83.37 | 51.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 508.76 | 33.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 1052.1 | 24.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1270.0 | 60.1 | Not reported | Not reported | Not reported |
|---|
AUC(0-inf) Hx-DR5-05 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 39.31 | 65.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 93.11 | 66.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 44.76 | 184.4 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 414.90 | 24.1 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 609.90 | 55.2 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2273.6 | 9.0 | Not reported | Not reported | Not reported |
|---|
AUC(0-inf) Hx-DR5-05 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 5 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in µg*h/mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 25.87 | 57.3 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 51.36 | 161.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 67.23 | 200.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 231.49 | 53.2 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 412.87 | 64.1 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2398.5 | NA | Not reported | Not reported | Geometric coefficient of variation was not derived as only one participant was evaluated for this arm. |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 50.2
- value
- 39.44
- group Id
- OG001
- spread
- 66.0
- value
- 91.20
- group Id
- OG002
- spread
- 56.7
- value
- 85.80
- group Id
- OG003
- spread
- 47.5
- value
- 523.66
- group Id
- OG004
- spread
- 22.7
- value
- 1298.0
- group Id
- OG005
- spread
- 58.7
- value
- 1497.7
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-01 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 61.5
- value
- 46.37
- group Id
- OG001
- spread
- 55.8
- value
- 105.32
- group Id
- OG002
- spread
- 30.5
- value
- 35.24
- group Id
- OG003
- spread
- 24.8
- value
- 530.48
- group Id
- OG004
- spread
- 30.7
- value
- 1071.5
- group Id
- OG005
- spread
- 10.7
- value
- 2488.5
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 7
- group Id
- OG004
- value
- 4
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-01 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 74.0
- value
- 37.43
- group Id
- OG001
- spread
- 133.3
- value
- 53.24
- group Id
- OG002
- spread
- 84.9
- value
- 41.41
- group Id
- OG003
- spread
- 26.8
- value
- 422.32
- group Id
- OG004
- spread
- 36.6
- value
- 1097.8
- comment
- Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
- group Id
- OG005
- spread
- NA
- value
- 2653.5
- denoms
- counts
- group Id
- OG000
- value
- 6
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-01 Cycle 3 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 55.4
- value
- 32.97
- group Id
- OG001
- spread
- 66.9
- value
- 71.21
- group Id
- OG002
- spread
- 51.7
- value
- 83.37
- group Id
- OG003
- spread
- 33.0
- value
- 508.76
- group Id
- OG004
- spread
- 24.7
- value
- 1052.1
- group Id
- OG005
- spread
- 60.1
- value
- 1270.0
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 6
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-05 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 65.9
- value
- 39.31
- group Id
- OG001
- spread
- 66.6
- value
- 93.11
- group Id
- OG002
- spread
- 184.4
- value
- 44.76
- group Id
- OG003
- spread
- 24.1
- value
- 414.90
- group Id
- OG004
- spread
- 55.2
- value
- 609.90
- group Id
- OG005
- spread
- 9.0
- value
- 2273.6
- denoms
- counts
- group Id
- OG000
- value
- 7
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-05 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 57.3
- value
- 25.87
- group Id
- OG001
- spread
- 161.6
- value
- 51.36
- group Id
- OG002
- spread
- 200.5
- value
- 67.23
- group Id
- OG003
- spread
- 53.2
- value
- 231.49
- group Id
- OG004
- spread
- 64.1
- value
- 412.87
- comment
- Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
- group Id
- OG005
- spread
- NA
- value
- 2398.5
- denoms
- counts
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 2
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- AUC(0-inf) Hx-DR5-05 Cycle 3 Day 1
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 7
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- description
- The AUC(0-inf) of Hx-DR5-01 and Hx-DR5-05 are reported.
- dispersion Type
- Geometric Coefficient of Variation
- groups
- description
- Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
- id
- OG000
- title
- Biweekly Regimen (GEN1029 0.1 mg/kg)
- description
- Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG001
- title
- Biweekly Regimen (GEN1029 0.2 mg/kg)
- description
- Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG002
- title
- Biweekly Regimen (GEN1029 0.3 mg/kg)
- description
- Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG003
- title
- Biweekly Regimen (GEN1029 1.0 mg/kg)
- description
- Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG004
- title
- Biweekly Regimen (GEN1029 2.0 mg/kg)
- description
- Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG005
- title
- Biweekly Regimen (GEN1029 3.0 mg/kg)
- param Type
- GEOMETRIC_MEAN
- population Description
- PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
- reporting Status
- POSTED
- time Frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
- title
- Area Under Plasma Concentration-time Curve From Time Zero to Infinity (AUC[0-inf]) of Hx-DR5-01 and Hx-DR5-05
- type
- SECONDARY
- unit Of Measure
- µg*h/mL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice